Correlation Between Unicycive Therapeutics and MannKind Corp

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and MannKind Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and MannKind Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and MannKind Corp, you can compare the effects of market volatilities on Unicycive Therapeutics and MannKind Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of MannKind Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and MannKind Corp.

Diversification Opportunities for Unicycive Therapeutics and MannKind Corp

0.59

Correlation Coefficient

Unicycive Therapeutics  MannKind Corp

Very weak diversification

The 3 months correlation between Unicycive and MannKind is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and MannKind Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MannKind Corp and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with MannKind Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MannKind Corp has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and MannKind Corp go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and MannKind Corp

Given the investment horizon of 90 days Unicycive Therapeutics is expected to under-perform the MannKind Corp. In addition to that, Unicycive Therapeutics is 2.1 times more volatile than MannKind Corp. It trades about -0.07 of its total potential returns per unit of risk. MannKind Corp is currently generating about -0.13 per unit of volatility. If you would invest  659.00  in MannKind Corp on December 2, 2024 and sell it today you would lose (125.00) from holding MannKind Corp or give up 18.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Unicycive Therapeutics  vs.  MannKind Corp

Unicycive Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Unicycive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

MannKind Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days MannKind Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward-looking signals remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Unicycive Therapeutics and MannKind Corp

The main advantage of trading using opposite Unicycive Therapeutics and MannKind Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, MannKind Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MannKind Corp will offset losses from the drop in MannKind Corp's long position.

The idea behind Unicycive Therapeutics and MannKind Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..